Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Glaucoma Therapeutics
... CAGR of 3.5% over the analysis period 2024-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas Therapeutics & Diagnostics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and ... Read More
-
Vitiligo Therapeutics
... CAGR of 4.0% over the analysis period 2024-2030. Topical Therapeutics, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Dilated Cardiomyopathy Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Angiotensin II Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$258.2 Million by ... Read More
-
Alpha 1 Antitrypsin Deficiency Treatment
... Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Augmentation Therapy, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$2.0 Billion ... Read More
-
Migraine Drugs
... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Global Preclinical CRO Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Global Preclinical Software Market for Physiology DA and AS 2025-2029
... the forecast period. The report on the preclinical software for physiology DA and AS market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around ... Read More
-
Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029
... like oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is a major growth driver. Moreover, improved bioinformatics tools for data analysis and interpretation are enhancing the usability of NGS, driving its widespread adoption. “The ... Read More
-
Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033
... Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc. Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; ... Read More
-
Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033
... Inc.; Eli Lilly and Company; H. Lundbeck AS; Bayer AG Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical ... Read More
-
Global Drugs for Malaria Competitive Landscape Professional Research Report 2025
... Plasmodium genus. These drugs include antimalarial agents like chloroquine, artemisinin-based combination therapies (ACTs), mefloquine, atovaquone-proguanil, and others. The choice of drug depends on the specific Plasmodium species causing the infection and its resistance patterns. Antimalarials ... Read More
-
Healthcare Digital Twins Market Trends, Growth, Size- By Component, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
... state that the Global Healthcare Digital Twins Market is predicted to reach 9183.03 million by 2034 with a CAGR of 26.11%. Healthcare digital twins are virtual representations of physical systems, processes, or individuals within the ... Read More
-
Global Ovarian Cancer Drugs Market - 2024-2032
... during the forecast period 2024-2031. Ovarian cancer is the growth of abnormal cancerous cells in the ovaries, fallopian tube, or peritoneum- the major parts of the woman’s reproductive system. Ovaries are made up of different ... Read More
-
Global Antipsychotic Drugs Market - 2025-2032
... forecast period 2025-2032. Antipsychotic medications are an important class of psychiatric drugs prescribed to manage psychosis, which includes symptoms such as delusions, hallucinations, and disorganized thinking. These medications are primarily used to treat conditions like ... Read More
-
Global Asthma Drugs Market - 2025 - 2032
... during the forecast period 2025-2032. Asthma is a prevalent, chronic inflammatory condition that affects millions of individuals worldwide. It often leads to unplanned healthcare visits and results in missed school and workdays. Asthma is characterized ... Read More
-
Global Pain Management Drugs Market - 2025-2033
... during the forecast period 2024-2032. Pain management drugs also called analgesics, are medications aimed at alleviating pain. These are classified into several categories which majorly include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants, anticonvulsants, ... Read More
-
Global Nucleic Acid Therapeutics Market - 2025 - 2033
... of 10.9% during the forecast period 2025-2032. Nucleic acid therapeutics are a class of treatments that involve the use of nucleic acids, such as DNA, RNA, or modified forms of these molecules, to treat or ... Read More
-
Organs-on-Chips Market by Type of Product (organ based and disease based), Type of Organ (single organ based and multi organ based), Type of Single Organ based Model (liver, lung, brain, heart, intestine, kidney and other organs), Type of Material of Construction (polydimethylsiloxane, other polymer, glass and others), Purpose (research and therapeutic), Application Area (drug discovery / toxicity testing, cancer research, stem cell research, tissue engineering / regenerative medicine and others), End User (pharmaceutical and biotech companies, academic and research players, cosmetic industry players and other end users), Key Geographical Regions and Leading Players: Industry Trends and Global Forecasts, Till 2035
... of 25. 6% during the forecast period, till 2035. The opportunity for organ on a chip market has been distributed across the following segments: Type of Product Organ based Disease based Type of Organ Single ... Read More
-
Global Epilepsy Drugs Market - 2025 - 2032
... during the forecast period 2025-2032. Epilepsy is a chronic neurological disorder that affects approximately 50 million people worldwide. It is characterized by unpredictable seizures that can vary in severity and frequency. The condition can arise ... Read More
-
Global Parkinson’s Disease Therapeutics Market - 2024-2031
... during the forecast period 2024-2031. Parkinson's disease is a progressive movement disorder of the nervous system caused by the degeneration of nerve cells in the substantia nigra, a part of the brain that controls movement. ... Read More
-
Global Orphan Drugs Market - 2024-2032
... forecast period 2024-2032. Orphan drugs are the medication indicated to treat, prevent, or diagnose an orphan disease. As per the U.S. Food and Drug Administration (FDA), orphan disease is a rare condition with less than ... Read More
-
Global Sickle Cell Disease Treatment Market - 2025 - 2033
... of 11.3% during the forecast period 2024-2032. Sickle cell disease (SCD) is a group of inherited blood disorders characterized by abnormalities in hemoglobin production. These abnormal hemoglobin cells are sickle-shaped unlike the regular disc-shaped hence ... Read More
-
Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035
... CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been distributed across the following segments: Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide ... Read More
-
Metaverse in Healthcare Market by Component (Software, Hardware and Services), Type of Technology (Augmented Reality / Virtual Reality, Artificial Intelligence, Blockchain Technology, Mixed Reality and Other Technologies), Applications (Telehealth, Medical Training and Education, Drug Discovery and Personalized Medicine, Diagnosis, and Other Applications), End Users (MedTech Companies, Healthcare Providers, Biopharmaceutical, Biotechnology and Life Sciences Companies, Payers, and Patients), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America) and Key Players: Industry Trends and Global Forecasts, Till 2035
... at a CAGR of 31. 1% during the forecast period, till 2035. The opportunity for metaverse in healthcare market has been distributed across the following segments: Type of Technology Augmented Reality / Virtual Reality Artificial ... Read More
Research Assistance
